United States · FDA National Drug Code directory
Alfuzosin Hydrochloride extended release
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 69097-844_497e0a60-9b09-4dcc-8cc6-1f13196f2db4
- Product NDC
- 69097-844
- Form
- TABLET
- Composition / generic term
- Alfuzosin Hydrochloride
- Labeler
- Cipla USA Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20160630
- Source listing expiry
- 20261231
Source-listed ingredients
- ALFUZOSIN HYDROCHLORIDE — 10 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 30 TABLET in 1 BOTTLE (69097-844-02) · 69097-844-02
- 90 TABLET in 1 BOTTLE (69097-844-05) · 69097-844-05
- 100 TABLET in 1 BOTTLE (69097-844-07) · 69097-844-07
- 500 TABLET in 1 BOTTLE (69097-844-12) · 69097-844-12
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →